TW01001, a novel piperazinedione compound, induces mitotic arrest and autophagy in non-small cell lung cancer A549 cells

Mei Chuan Chen, Chun Han Chen, Yi Nan Liu, Hui Po Wang, Shiow Lin Pan, Che Ming Teng

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Here, we report that TW01001, a novel piperazinedione compound, could be a new mitotic inhibitor for the treatment of non-small cell lung cancer by the following observations in A549 cells: (1) induction of cells to accumulate at G2/M phase, which ultimately led to cell apoptotic death, (2) accumulation of p53 and inhibition of survival signalings, and (3) induction of p53-independent autophagy. Taken together, our data suggested that TW01001 induces autophagy-p53-signaling pathway to cause mitotic arrest and cell growth inhibition in A549 cells and provides the framework for further development as a novel therapeutic agent for lung cancer treatment.

Original languageEnglish
Pages (from-to)370-378
Number of pages9
JournalCancer Letters
Volume336
Issue number2
DOIs
Publication statusPublished - Aug 19 2013

Fingerprint

3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione
Autophagy
Non-Small Cell Lung Carcinoma
G2 Phase
Cell Division
Lung Neoplasms
Cell Death
Growth
A549 Cells
3-((6-((5-benzylidene-3,6-dioxopiperazin-2-ylidene)methyl)pyridin-3-yloxy)methyl)benzoic acid
Therapeutics

Keywords

  • Apoptosis
  • Autophagy
  • Lung cancer
  • Mitotic arrest
  • Signal transduction

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

TW01001, a novel piperazinedione compound, induces mitotic arrest and autophagy in non-small cell lung cancer A549 cells. / Chen, Mei Chuan; Chen, Chun Han; Liu, Yi Nan; Wang, Hui Po; Pan, Shiow Lin; Teng, Che Ming.

In: Cancer Letters, Vol. 336, No. 2, 19.08.2013, p. 370-378.

Research output: Contribution to journalArticle

@article{a48257630973415c9f1095ccc9837478,
title = "TW01001, a novel piperazinedione compound, induces mitotic arrest and autophagy in non-small cell lung cancer A549 cells",
abstract = "Here, we report that TW01001, a novel piperazinedione compound, could be a new mitotic inhibitor for the treatment of non-small cell lung cancer by the following observations in A549 cells: (1) induction of cells to accumulate at G2/M phase, which ultimately led to cell apoptotic death, (2) accumulation of p53 and inhibition of survival signalings, and (3) induction of p53-independent autophagy. Taken together, our data suggested that TW01001 induces autophagy-p53-signaling pathway to cause mitotic arrest and cell growth inhibition in A549 cells and provides the framework for further development as a novel therapeutic agent for lung cancer treatment.",
keywords = "Apoptosis, Autophagy, Lung cancer, Mitotic arrest, Signal transduction",
author = "Chen, {Mei Chuan} and Chen, {Chun Han} and Liu, {Yi Nan} and Wang, {Hui Po} and Pan, {Shiow Lin} and Teng, {Che Ming}",
year = "2013",
month = "8",
day = "19",
doi = "10.1016/j.canlet.2013.03.028",
language = "English",
volume = "336",
pages = "370--378",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - TW01001, a novel piperazinedione compound, induces mitotic arrest and autophagy in non-small cell lung cancer A549 cells

AU - Chen, Mei Chuan

AU - Chen, Chun Han

AU - Liu, Yi Nan

AU - Wang, Hui Po

AU - Pan, Shiow Lin

AU - Teng, Che Ming

PY - 2013/8/19

Y1 - 2013/8/19

N2 - Here, we report that TW01001, a novel piperazinedione compound, could be a new mitotic inhibitor for the treatment of non-small cell lung cancer by the following observations in A549 cells: (1) induction of cells to accumulate at G2/M phase, which ultimately led to cell apoptotic death, (2) accumulation of p53 and inhibition of survival signalings, and (3) induction of p53-independent autophagy. Taken together, our data suggested that TW01001 induces autophagy-p53-signaling pathway to cause mitotic arrest and cell growth inhibition in A549 cells and provides the framework for further development as a novel therapeutic agent for lung cancer treatment.

AB - Here, we report that TW01001, a novel piperazinedione compound, could be a new mitotic inhibitor for the treatment of non-small cell lung cancer by the following observations in A549 cells: (1) induction of cells to accumulate at G2/M phase, which ultimately led to cell apoptotic death, (2) accumulation of p53 and inhibition of survival signalings, and (3) induction of p53-independent autophagy. Taken together, our data suggested that TW01001 induces autophagy-p53-signaling pathway to cause mitotic arrest and cell growth inhibition in A549 cells and provides the framework for further development as a novel therapeutic agent for lung cancer treatment.

KW - Apoptosis

KW - Autophagy

KW - Lung cancer

KW - Mitotic arrest

KW - Signal transduction

UR - http://www.scopus.com/inward/record.url?scp=84879785179&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879785179&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2013.03.028

DO - 10.1016/j.canlet.2013.03.028

M3 - Article

VL - 336

SP - 370

EP - 378

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 2

ER -